Keyphrases
Neuroprotective Effect
100%
Ligand-receptor Binding
100%
Nitric Oxide Production
100%
Piperidine
100%
A1 Receptor
100%
Phenyl
100%
Neuronal Nitric Oxide
100%
Neuronal Nitric Oxide Synthase (nNOS)
45%
Infarction Volume
36%
Transient Middle Cerebral Artery Occlusion (tMCAO)
27%
7-nitroindazole
27%
Ischemia
18%
Reperfusion
18%
Striatum
18%
Striatal
18%
Occlusion
18%
Attenuation
9%
Neuroprotection
9%
Microdialysis
9%
Tissue Damage
9%
Neurotoxicity
9%
Histology
9%
Wild Mice
9%
Combination Therapy
9%
Ischemic Brain
9%
Non-ischemic
9%
Nitric Oxide Synthase Inhibitors
9%
Adult Male
9%
Arginine
9%
Nitric Oxide Synthase Activity
9%
Wild Strain
9%
Citrulline
9%
Ischemic Insult
9%
Wistar Rats
9%
Cerebral Cortex
9%
Halothane
9%
Early Reperfusion
9%
2,3,5-triphenyltetrazolium Chloride
9%
Experimental Stroke
9%
Physiological Variables
9%
Null mutant
9%
Intraluminal Filament
9%
Mechanisms of Neuroprotection
9%
Selective Neuronal Nitric Oxide Synthase Inhibitors
9%
INIS
production
100%
receptors
100%
nitric oxide
100%
ligands
100%
piperidines
100%
ischemia
41%
volume
33%
cerebral arteries
25%
mice
16%
in vivo
16%
brain
16%
hypothesis
8%
rats
8%
data
8%
tissues
8%
recovery
8%
attenuation
8%
damage
8%
adults
8%
strains
8%
reduction
8%
mutants
8%
inhibition
8%
histology
8%
males
8%
infusion
8%
combined therapy
8%
arginine
8%
chlorides
8%
filaments
8%
citrulline
8%
cerebral cortex
8%
Neuroscience
Nitric Oxide
100%
Neuroprotective Agent
100%
Eicosanoid Receptor
100%
Piperidine
100%
Neuronal Nitric Oxide Synthase
54%
Infarction
36%
Middle Cerebral Artery
27%
7-Nitroindazole
27%
Brain
18%
Neuroprotection
18%
In Vivo
18%
Ischemia
18%
Striatum
18%
Microdialysis
9%
Neurotoxicity
9%
Stroke
9%
Arginine
9%
Cerebral Cortex
9%
Histology
9%
Halothane
9%
Citrulline
9%
Chloride
9%